Telehealth program for weight management and related health issues
Official title: OneSTOP (One-Stop Telehealth Obesity Program): the Use of Telecare and Digital Platforms for Multidisciplinary Management of Weight Management and Related Comorbidities
Run by Changi General Hospital · NCT06890169 · Data updated 2026-11-12
This study is testing a new telehealth program for weight management to see if it helps obese adults with type 2 diabetes and liver issues lose weight and improve their health better than traditional in-person programs.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 70 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Changi General Hospital Academic / other |
| Locations | 1 site (Singapore) |
| Status | Recruiting |
| Started | May 1, 2025 |
| Main results expected | February 28, 2027 |
| Study ends | August 31, 2027 |
| Registry record updated | March 21, 2025 |
| Trial ID | NCT06890169 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 21-70 with a BMI greater than 27.5 kg/m2 and suboptimal control of type 2 diabetes or MASLD.
✕Probably not a fit
Patients with a life expectancy of less than 6 months or those unable to comply with written instructions in English may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of the OneSTOP Telehealth Obesity Program, which combines teleconsultations and the EMPOWER app, in inducing significant weight loss and metabolic improvements in obese adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD). Participants will be randomly assigned to either the OneSTOP program or a conventional face-to-face weight management program over a 26-week period. The study will compare the outcomes of both approaches in terms of weight loss, patient convenience, and adherence to dietary and exercise recommendations.
Why it matters
Potential benefit: If successful, this program could provide a more accessible and effective method for managing obesity and related metabolic conditions.
How similar studies have gone: Other studies have shown promising results with telehealth approaches for weight management, indicating potential for success in this novel intervention.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 21-70 * Body mass index \> 27.5 kg/m2 * Waist circumference \> 90 cm in men or 80 cm in women * Suboptimal control of type 2 diabetes (HbA1c \> 6.5%) AND/OR MASLD (as defined on radiological or histological evidence of hepatic steatosis in the absence of other chronic liver disease) Exclusion Criteria: * Men who drink \> 21 units/week and women who drink \> 14 units/week of alcohol * Participants previously on weight-lowering medications (however if they are keen to participate, there will be a minimum wash-out period of 3 months before participation) * Illness with life expectancy of less than 6 months * Inability to comply with written instructions in English
Where it's running
-
Changi General Hospital
Singapore, Singapore Recruiting
Study contacts
- Principal investigator: Joan Khoo, MBBS, FRCP — Changi General Hospital
- Study coordinator: Joan Khoo, MBBS, FRCP
- Email: joan.khoo.j.c@singhealth.com.sg
- Phone: +65 69365641
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Low‑methoxy pectin for inflammation, gut microbiome, and metabolic health in MASLD
This tests whether taking daily low‑methoxy pectin for six weeks can reduce inflammation and improve gut bacteria and metabolic markers in adults with MASLD.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
A registry for studying Non-Alcoholic Fatty Liver Disease in Europe
This study is collecting health information and samples from people with Non-Alcoholic Fatty Liver Disease to learn more about the disease and find better ways to track its progress.
-
Outpatient Cardiac Telerehabilitation for Ischemic Heart Disease
This study tests whether an outpatient cardiac telerehabilitation program can be as safe and effective as conventional rehab for people with ischemic heart disease.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.